$45M Deal In IRhythm Heart Device Investor Suit Gets Final OK
A California federal court granted final approval to a $45 million settlement resolving proposed class action allegations that digital healthcare company iRhythm Technologies inflated stock prices with misrepresentations about its heart-event...To view the full article, register now.
Already a subscriber? Click here to view full article